Navigation Links
ClinicalRM to Co-Present Regulatory Compliance Panel at MAGI
Date:10/26/2011

LAS VEGAS, Oct. 26, 2011 /PRNewswire/ -- Clinical Research Management, (ClinicalRM) a full-service Contract Research Organization providing services for basic and applied research, clinical trials, and regulatory support, announced today its Senior Scientific Director, Dr. Jere M. Boyer, Ph.D., will co-present a panel titled Battle of Compliance: FDA vs. OHRP vs. ICH at the MAGI West Clinical Research Conference, October 23-26, 2011 in Las Vegas, NV.  The panel will discuss the important differences in clinical research regulations, guidelines and guidances between the United States Food and Drug Administration (FDA), the United States Department of Health and Human Resources Office for Human Research Protections (OHRP), and the International Conference on Harmonization (ICH).  MAGI is the Model Agreements and Guidelines International organization whose mission is to standardize best practices for clinical research operations, business, and regulatory compliance.

Dr. Boyer, a Certified IRB Manager (CIM), Certified IRB Professional (CIP), Certified Clinical Research Professional (CCRP), and a Clinical Laboratory Director/Diplomat in Clinical Microbiology for the American Board of Bioanalysis, is an established speaker and author, with specific focus on the growing complexity of managing Human Subject Protection over the past decade.

"The MAGI conference presents a great forum for sharing our collective expertise in compliance across regulatory groups that affect clinical research management," said Victoria Tifft, founder and CEO of ClinicalRM.  Said Tifft, "Dr. Boyer is an expert on the topic of Human Subject Protection and will offer valuable insight into the accountability and execution of these types of requirements in the clinical setting."

About ClinicalRM

Founded in 1992, ClinicalRM is a full service Contract Research Organization (CRO) specializing in preclinical, and Phase I to Phase IV clinical research, clinical trial support, and product development for biologics, drugs, and devices. ClinicalRM pride's itself on providing outstanding customer service and exceeding client expectations. For more information, please go to: www.clinicalrm.com

Contact:
Dana Stanton
dstanton@clinicalrm.com
Ph: 800-431-9640   Fax: 800-538-1420
For General Information: info@clinicalrm.com


'/>"/>
SOURCE Clinical Research Management (ClinicalRM)
Copyright©2010 PR Newswire.
All rights reserved

Related medicine technology :

1. Clinical Research Management, a Full-Service CRO, Changes Its Name to ClinicalRM
2. FDA Invests $2 Million in Partnerships Through Centers of Excellence in Regulatory Science and Innovation
3. Delcath Announces Completion of Regulatory Notification Process in New Zealand
4. Boston Scientific Welcomes Introduction of Medical Device Regulatory Improvement Act in U.S. Senate
5. Insmed Incorporated Provides Regulatory Update on ARIKACE® in Non-Tuberculous Mycobacteria Indication
6. Insmed Incorporated Provides Regulatory Update
7. EMDT Launches New Specialist Conference on Managing Regulatory Change for Medical Devices
8. Genesis Biopharma Adds Cell Therapy Bioprocess Engineering, Clinical Trial Design, Biostatistics, Regulatory Affairs and FDA Compliance Expertise
9. VIVUS Provides Regulatory Update on QNEXA
10. Novo Nordisk Inc. Appoints Eddie Li as Vice President, Regulatory Affairs
11. Top 20 Contract Research Organizations (CRO) - Asia-Pacific, Especially India and China, Positioned to Benefit from Rising Financial and Regulatory Pressures in Western Pharmaceutical Markets
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... , Feb. 10, 2016  Visage Imaging Inc. ... Ltd. (ASX: PME), has announced that the American College ... (UF) have selected the Visage 7 Enterprise Imaging ... the Emergent/Critical Care Imaging SIMulation (SIM). SIM is ... Imaging Program (WIDI), a multi-faceted and fully-integrated online ...
(Date:2/10/2016)... DIEGO , Feb. 10, 2016 ... company developing novel, clinical-stage therapies for sickle cell disease ... underwritten public offering of 29,090,910 units at a price ... consists of one share of the Company,s common stock ... Company,s common stock at an exercise price of $0.42 ...
(Date:2/10/2016)... Antibacterial Drugs Market - Global Industry ... ", reveals that the global antibacterial drugs market is forecast ... owing to patent expiries of blockbuster drugs. Even though the ... forecast period, the value is anticipated to decline from US$43.9 ... Antibacterial Drugs Market - Global Industry Analysis, Size, Share, ...
Breaking Medicine Technology:
(Date:2/10/2016)... ... February 10, 2016 , ... Intermedix ... of Emergency Medicine , an emergency medicine professional association, to support the organization's ... , The American Academy of Emergency Medicine, or AAEM, seeks to empower emergency ...
(Date:2/10/2016)... SAN FRANCISCO, Calif. (PRWEB) , ... February 10, 2016 , ... ... category: Best Water Brand. There were three leading bottled water brand owners that topped ... edge services that enhance connectivity and optimize conversion. The premier brand was Tibet 5100, ...
(Date:2/10/2016)... ... February 10, 2016 , ... Intalere’s 2016 Executive Forum, ... 200 of the country’s top healthcare executives to share insights on transformational strategies ... the Forum is the provider-centric perspective, experience, expertise and strategy shared by the ...
(Date:2/10/2016)... ... 2016 , ... Armune BioScience signed a definitive agreement with ... centers across the country. Launched in April of 2015, Apifiny is the only cancer ... Apifiny order volume exceeded 3,000 tests in 2015. Primary care physicians and urologists have ...
(Date:2/10/2016)... (PRWEB) , ... February 10, 2016 , ... ... it will attend the Ohio Safety Congress and Expo event March 9-11, 2016. ... the Greater Columbus Convention Center. , As the longest running and largest ...
Breaking Medicine News(10 mins):